<p>犹他医疗产品（NASDAQ:UTMD - 获取免费报告）于周四发布了季度财报。根据 Zacks 的报告，该医疗器械供应商本季度每股收益为 0.80 美元。犹他医疗产品的股本回报率为 9.89%，净利润率为 30.08%。</p>
<p>获取 <strong>犹他医疗产品</strong> 的提醒：</p>
<h2>犹他医疗产品股票表现</h2>
<p>周四中午交易时，UTMD 股票上涨 0.02 美元，达到 60.86 美元。该公司的股票交易量为 685 股，而其平均交易量为 13,361 股。该公司的市值为 1.9474 亿美元，市盈率为 17.23，贝塔值为 0.33。该公司的 50 日简单移动平均线为 57.71 美元，200 日简单移动平均线为 58.80 美元。犹他医疗产品的 52 周低点为 51.26 美元，52 周高点为 64.46 美元。</p>
<h2>犹他医疗产品增加股息</h2>
<p>该公司最近还披露了季度股息，已于 1 月 5 日（星期一）支付。12 月 16 日（星期二）登记在册的股东获得了 0.31 美元的股息。这比犹他医疗产品之前的季度股息 0.31 美元有所增加。该股息的除息日期为 12 月 16 日（星期二）。这代表着年化股息为 1.24 美元，股息收益率为 2.0%。犹他医疗产品的股息支付比率为 35.03%。</p>
<h2>分析师设定新目标价</h2>
<p>另外，Weiss Ratings 在 1 月 21 日（星期三）的一份研究报告中重新发布了对犹他医疗产品股票的 “卖出（d+）” 评级。一位投资分析师对该股票给予了卖出评级，根据 MarketBeat.com 的数据，该股票的共识评级为 “卖出”。</p>
<p><strong>查看我们关于犹他医疗产品的最新研究报告</strong></p>
<h2>机构投资者对犹他医疗产品的看法</h2>
<p>一些对冲基金最近增加或减少了对该公司的持股。Comerica Bank 在第三季度将其在犹他医疗产品的持股增加了 435.6%。Comerica Bank 现在拥有 541 股该医疗器械供应商的股票，价值 34,000 美元，此前在该期间又购买了 440 股。BNP Paribas Financial Markets 在第三季度将其在犹他医疗产品的持股增加了 89.6%。BNP Paribas Financial Markets 现在拥有 1,060 股该医疗器械供应商的股票，价值 67,000 美元，此前在上个季度又收购了 501 股。怀俄明州在第二季度购买了犹他医疗产品的新股份，价值 132,000 美元。Advisory Services Network LLC 在第三季度收购了犹他医疗产品的新头寸，价值 159,000 美元。最后，Russell Investments Group Ltd.在第二季度将其在犹他医疗产品的持股增加了 550.5%。Russell Investments Group Ltd.现在拥有 2,758 股该医疗器械供应商的股票，价值 157,000 美元，此前在上个季度又收购了 2,334 股。目前 69.60% 的股票由机构投资者持有。</p>
<h2>犹他医疗产品公司简介</h2>
<p>（获取免费报告）</p>
<p>犹他医疗产品公司（Utah Medical Products, Inc.）NASDAQ: UTMD，总部位于犹他州米德维尔，是一家专注于呼吸治疗和病人监测应用的一次性医疗设备的设计、制造和营销公司。自 1970 年代末成立以来，该公司在气道管理和用于急性和长期护理环境的非侵入性监测产品方面建立了创新的声誉。</p>
<p>该公司的核心产品组合包括气管切开管及相关配件、气管插管固定器、一次性导管和用于测量呼气末二氧化碳（CO₂）的传感器。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过犹他医疗产品</li>
<li>家族信托如何帮助保护您的财富</li>
<li>请勿删除，立即阅读</li>
<li>1933 年退款：特朗普的重置可能创造即时财富</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>用这四个简单步骤 “防止美联储影响” 您的银行账户</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VVRNRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VVRNRA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资 1,000 美元于犹他医疗产品吗？</h2>
<p>在您考虑犹他医疗产品之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而犹他医疗产品并不在名单上。</p>
<p>虽然犹他医疗产品目前在分析师中被评为卖出评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

犹他医疗产品

<p>犹他医疗产品 (NASDAQ:UTMD) 报告了季度每股收益为 $0.80，净利润率为 30.08%，股本回报率为 9.89%。该股票交易价格为 $60.86，市值为 $1.9474 亿。公司还宣布季度分红为 $0.31，维持 2.0% 的收益率。分析师对该股票的共识评级为 “卖出”，近期机构投资显著增加。犹他医疗产品专注于一次性医疗设备，特别是在呼吸治疗和患者监测领域</p>

<p>Utah Medical Products (NASDAQ:UTMD - Get Free Report) posted its quarterly earnings data on Thursday. The medical instruments supplier reported $0.80 earnings per share for the quarter, Zacks reports. Utah Medical Products had a return on equity of 9.89% and a net margin of 30.08%.</p>
<div class="lb-trans"><p>犹他医疗产品（NASDAQ:UTMD - 获取免费报告）于周四发布了季度财报。根据 Zacks 的报告，该医疗器械供应商本季度每股收益为 0.80 美元。犹他医疗产品的股本回报率为 9.89%，净利润率为 30.08%。</p>
</div><p>Get <strong>Utah Medical Products</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>犹他医疗产品</strong> 的提醒：</p>
</div><h2>Utah Medical Products Stock Performance</h2>
<div class="lb-trans"><h2>犹他医疗产品股票表现</h2>
</div><p>Shares of UTMD stock traded up $0.02 during mid-day trading on Thursday, hitting $60.86. The company's stock had a trading volume of 685 shares, compared to its average volume of 13,361. The company has a market cap of $194.74 million, a PE ratio of 17.23 and a beta of 0.33. The company's fifty day simple moving average is $57.71 and its 200-day simple moving average is $58.80. Utah Medical Products has a 52 week low of $51.26 and a 52 week high of $64.46.</p>
<div class="lb-trans"><p>周四中午交易时，UTMD 股票上涨 0.02 美元，达到 60.86 美元。该公司的股票交易量为 685 股，而其平均交易量为 13,361 股。该公司的市值为 1.9474 亿美元，市盈率为 17.23，贝塔值为 0.33。该公司的 50 日简单移动平均线为 57.71 美元，200 日简单移动平均线为 58.80 美元。犹他医疗产品的 52 周低点为 51.26 美元，52 周高点为 64.46 美元。</p>
</div><h2>Utah Medical Products Increases Dividend</h2>
<div class="lb-trans"><h2>犹他医疗产品增加股息</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Monday, January 5th. Stockholders of record on Tuesday, December 16th were given a $0.31 dividend. This is a boost from Utah Medical Products's previous quarterly dividend of $0.31. The ex-dividend date of this dividend was Tuesday, December 16th. This represents a $1.24 annualized dividend and a dividend yield of 2.0%. Utah Medical Products's dividend payout ratio is 35.03%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，已于 1 月 5 日（星期一）支付。12 月 16 日（星期二）登记在册的股东获得了 0.31 美元的股息。这比犹他医疗产品之前的季度股息 0.31 美元有所增加。该股息的除息日期为 12 月 16 日（星期二）。这代表着年化股息为 1.24 美元，股息收益率为 2.0%。犹他医疗产品的股息支付比率为 35.03%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Separately, Weiss Ratings reissued a &#34;sell (d+)&#34; rating on shares of Utah Medical Products in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of &#34;Sell&#34;.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 1 月 21 日（星期三）的一份研究报告中重新发布了对犹他医疗产品股票的 “卖出（d+）” 评级。一位投资分析师对该股票给予了卖出评级，根据 MarketBeat.com 的数据，该股票的共识评级为 “卖出”。</p>
</div><p><strong>Check Out Our Latest Research Report on Utah Medical Products</strong></p>
<div class="lb-trans"><p><strong>查看我们关于犹他医疗产品的最新研究报告</strong></p>
</div><h2>Institutional Investors Weigh In On Utah Medical Products</h2>
<div class="lb-trans"><h2>机构投资者对犹他医疗产品的看法</h2>
</div><p>A number of hedge funds have recently added to or reduced their stakes in the business. Comerica Bank lifted its stake in Utah Medical Products by 435.6% in the third quarter. Comerica Bank now owns 541 shares of the medical instruments supplier's stock valued at $34,000 after buying an additional 440 shares during the period. BNP Paribas Financial Markets increased its stake in shares of Utah Medical Products by 89.6% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,060 shares of the medical instruments supplier's stock valued at $67,000 after acquiring an additional 501 shares in the last quarter. State of Wyoming bought a new stake in shares of Utah Medical Products in the 2nd quarter valued at $132,000. Advisory Services Network LLC acquired a new position in shares of Utah Medical Products during the 3rd quarter valued at $159,000. Finally, Russell Investments Group Ltd. boosted its stake in Utah Medical Products by 550.5% during the second quarter. Russell Investments Group Ltd. now owns 2,758 shares of the medical instruments supplier's stock worth $157,000 after acquiring an additional 2,334 shares in the last quarter. 69.60% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些对冲基金最近增加或减少了对该公司的持股。Comerica Bank 在第三季度将其在犹他医疗产品的持股增加了 435.6%。Comerica Bank 现在拥有 541 股该医疗器械供应商的股票，价值 34,000 美元，此前在该期间又购买了 440 股。BNP Paribas Financial Markets 在第三季度将其在犹他医疗产品的持股增加了 89.6%。BNP Paribas Financial Markets 现在拥有 1,060 股该医疗器械供应商的股票，价值 67,000 美元，此前在上个季度又收购了 501 股。怀俄明州在第二季度购买了犹他医疗产品的新股份，价值 132,000 美元。Advisory Services Network LLC 在第三季度收购了犹他医疗产品的新头寸，价值 159,000 美元。最后，Russell Investments Group Ltd.在第二季度将其在犹他医疗产品的持股增加了 550.5%。Russell Investments Group Ltd.现在拥有 2,758 股该医疗器械供应商的股票，价值 157,000 美元，此前在上个季度又收购了 2,334 股。目前 69.60% 的股票由机构投资者持有。</p>
</div><h2>Utah Medical Products Company Profile</h2>
<div class="lb-trans"><h2>犹他医疗产品公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Utah Medical Products, Inc NASDAQ: UTMD, headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.</p>
<div class="lb-trans"><p>犹他医疗产品公司（Utah Medical Products, Inc.）NASDAQ: UTMD，总部位于犹他州米德维尔，是一家专注于呼吸治疗和病人监测应用的一次性医疗设备的设计、制造和营销公司。自 1970 年代末成立以来，该公司在气道管理和用于急性和长期护理环境的非侵入性监测产品方面建立了创新的声誉。</p>
</div><p>The company's core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).</p>
<div class="lb-trans"><p>该公司的核心产品组合包括气管切开管及相关配件、气管插管固定器、一次性导管和用于测量呼气末二氧化碳（CO₂）的传感器。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Utah Medical Products</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Do not delete, read immediately</li>
<li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过犹他医疗产品</li>
<li>家族信托如何帮助保护您的财富</li>
<li>请勿删除，立即阅读</li>
<li>1933 年退款：特朗普的重置可能创造即时财富</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>用这四个简单步骤 “防止美联储影响” 您的银行账户</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VVRNRA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=UTMD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Utah Medical Products Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元于犹他医疗产品吗？</h2>
</div><p>Before you consider Utah Medical Products, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑犹他医疗产品之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而犹他医疗产品并不在名单上。</p>
</div><p>While Utah Medical Products currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然犹他医疗产品目前在分析师中被评为卖出评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

犹他医疗产品（NASDAQ:UTMD）公布季度财报结果